Open Aortic Stapler (OAS), a product from Israel based ES Vascular Ltd., is designed to simplify the anastomosis of synthetic graft to the aorta during AAA repair. The company is reporting that its stapler is past the development stage, and is now awaiting CE Mark of approval from the European Union. The company is working on other products, such as Endovascular Stapler (EVAS) “designed to fixate stent-grafts in place potentially preventing migration and possibly endoleakage,” and CLI Endostapler that “will facilitate a minimally invasive procedure that can replace an open femoral-popliteal bypass (FPB) operation.”
More about the Open Aortic Stapler:
ES Vascular’s single use Open Aortic Stapler (OAS) provides a one-shot, perfect anastomosis while connecting a synthetic graft to the aorta for AAA repair.
The quick, uniform, one-shot sutureless anastomosis may eliminate up to 90% of suturing time and reduce clamping and operative times as well as re-clamping cycles and bleeding.
AAA procedures are mostly open, dangerous (ca. 5% mortality), lengthy (2-3hrs) and require quite a long in-hospital stay Suturing the difficult graft-aorta anastomosis accounts for both long clamping times (up to 50% of operative time) and re-clamping cycles, a major risk for the patient Technical obstacles (e.g. highly calcified aorta) hampered the development of stapling technology for vascular surgery to date ES Vascular’s Open Stapler creates a quick, uniform, one-shot sutureless anastomosis and may eliminate up to 90% of suturing time, reduce clamping and operative times as well as re-clamping cycles and bleeding